Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Profit After Tax

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Profit After Tax History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit After Tax ₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr₹12 Cr

What is the latest Profit After Tax of MEDICAMEN BIOTECH ?

The latest Profit After Tax ratio of MEDICAMEN BIOTECH is ₹15 Cr based on Mar2024 Consolidated results.
Year Profit After Tax
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr
Mar2020₹12 Cr

How is Profit After Tax of MEDICAMEN BIOTECH Trending?

Years Profit After Tax % Change
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr
10.52
Mar2020 ₹12 Cr -

Compare Profit After Tax of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹508.8 Cr -2.5% -4.9% -5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹383,570.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,808.0 Cr -7.1% -11.5% 32.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,734.0 Cr -5.8% 6.1% 13.3% Stock Analytics
CIPLA ₹120,468.0 Cr -4.3% -0.1% -1% Stock Analytics
DR REDDYS LABORATORIES ₹100,212.0 Cr -5.8% -6.8% -11% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.5%

-4.9%

-5%

SENSEX

-0.7%

-3.7%

2.4%


You may also like the below Video Courses